@FiercePharma: FDA isn't getting post-marketing data on fast-tracked drugs, per JAMA. Required studies undone or unreported. JAMA report | Follow @FiercePharma
@CarlyHFierce: Biogen's Tecfidera drives rosy Q3 results, higher forecast. ICYMI yesterday | Follow @CarlyHFierce
> Allergan ($AGN) agreed to sell its obesity unit to Apollo Endosurgery for $75 million up front, plus a potential $15 million equity interest in the company, plus up to $20 million in milestone payments. Report | FierceMedicalDevices story
> AstraZeneca ($AZN) shares bounced yesterday after Merrill Lynch advised short sellers to close their positions in advance of news on its pipeline drugs; the company reports earnings Thursday. Report
> Hi-Tech Pharmacal settled a class-action lawsuit that claimed its advertising for allergy drug Nasal Ease was misleading. Report
> Brazil's Hypermarcas, a top generics producer in the country, plans to buy back $300 million in bonds to reduce debt. Report
@FierceMedDev: DOD agency commits $70M to develop brain-monitoring implant. Item | Follow @FierceMedDev
@MarkHFierce: Apollo Endosurgery, a 2012 Fierce 15 winner, aims for big growth by snatching up Allergan's obesity device business. Story | Follow @MarkHFierce
@MichaelGFierce: ICYMI: A blog post from the FDA late last week highlighted the agency's efforts to regulate nanotechnology. Blog | Follow @MichaelGFierce
> St. Jude Medical touts positive preliminary results for Portico heart valve. Article
> Edwards slips as so-so outlook leaves investors underwhelmed. Report
> Covidien flips surgical sealants to Integra for $235M. More
Biotech News
@FierceBiotech: Popular on FierceCRO.com: InVentiv opens U.K. hub as EU demand climbs. Article | Follow @FierceBiotech
@JohnCFierce: The ax drops at troubled Merck as big restructuring gets underway. Story | Follow @JohnCFierce
@DamianFierce: Ex-Calistoga chief Gallagher joins VC Frazier Healthcare to steer biotech bets. News | Follow @DamianFierce
> Sanofi, Glaxo sign up for vaccine R&D projects under new Gates initiative. Story
> Calithera grabs $35M round to fund first slate of cancer drug studies. More
> Eli Lilly partners with Pfizer on its high-risk PhIII pain med tanezumab. News
Pharma Manufacturing News
@EricPFierce: What drugs are up for grabs by generic makers next year? Here's the FiercePharma list of 2014 patent losses. | Follow @EricPFierce
> Wockhardt profits crater after U.S., U.K. plant bans. More
> Manufacturing glitch leaves Novo insulin cartridges with bad fills. Report
> Gilead expanding facility that makes highly anticipated hep C drug. Story
> India's plan to inspect China plants stalled. Article
Biotech Research News
@EmilyMFierce: I took a look at 5 promising preclinical drug programs across industry/academia for this latest report. Feature | Follow @EmilyMFierce
> Fast-acting antidepressants discovered. Report
> New obstacle found in search for HIV/AIDS cure. Item
> Certain microRNAs might be viable Alzheimer's targets. Article
> CytomX 'probody' kills pancreatic cancer cells, leaves healthy tissue intact. Story
And Finally... In almost every European country, bikes are outselling new cars. Report